Skip to content
10-Q

Quarterly Report

Karyopharm Therapeutics Inc. KPTI

0000950170-25-106238

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 8.67M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.62K sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.55K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 10.3K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 8.47K sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $195K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$57.68M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$82.22M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $38.73M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $62.48M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $84.77M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$238.93M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$205.88M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$186.02M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$132.14M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$168.96M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$136.21M
Current Liabilities Q2 2025 · Jun 30, 2025 $99.22M
Current Liabilities Q2 2025 · Dec 31, 2024 $92.26M
Total Liabilities Q2 2025 · Jun 30, 2025 $343.81M
Total Liabilities Q2 2025 · Dec 31, 2024 $350.44M
Current Assets Q2 2025 · Jun 30, 2025 $97.87M
Current Assets Q2 2025 · Dec 31, 2024 $156.46M
Total Assets Q2 2025 · Jun 30, 2025 $104.88M
Total Assets Q2 2025 · Dec 31, 2024 $164.42M
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.32
Eps Diluted Q2 2025 · Jun 30, 2025 −$7.11
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$2.97
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$7.16
Eps Basic Q2 2025 · Jun 30, 2025 −$4.32
Eps Basic Q2 2025 · Jun 30, 2025 −$7.11
Eps Basic restated Q2 2025 · Jun 30, 2024 $2.26
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1.72
Sga Expense Q2 2025 · Jun 30, 2025 $28.48M
Sga Expense Q2 2025 · Jun 30, 2025 $55.83M
Sga Expense Q2 2025 · Jun 30, 2024 $31.07M
Sga Expense Q2 2025 · Jun 30, 2024 $60.62M
Rd Expense Q2 2025 · Jun 30, 2025 $32.79M
Rd Expense Q2 2025 · Jun 30, 2025 $67.41M
Rd Expense Q2 2025 · Jun 30, 2024 $38.37M
Rd Expense Q2 2025 · Jun 30, 2024 $73.8M
Net Income Q2 2025 · Jun 30, 2025 −$37.25M
Net Income Q2 2025 · Jun 30, 2025 −$60.71M
Net Income Q2 2025 · Jun 30, 2024 $23.79M
Net Income Q2 2025 · Jun 30, 2024 −$13.57M
Operating Income Q2 2025 · Jun 30, 2025 −$24.39M
Operating Income Q2 2025 · Jun 30, 2025 −$57.64M
Operating Income Q2 2025 · Jun 30, 2024 −$28.12M
Operating Income Q2 2025 · Jun 30, 2024 −$61.88M
Revenue Q2 2025 · Jun 30, 2025 $37.93M
Revenue Q2 2025 · Jun 30, 2025 $67.94M
Revenue Q2 2025 · Jun 30, 2024 $42.79M
Revenue Q2 2025 · Jun 30, 2024 $75.91M